Integral-based identification of a physiological insulin and glucose model on euglycaemic clamp and

Abstract Modelling can enhance the diagnosis and control of metabolic disorders. Clinical effectiveness demands physiological accuracy, patient specificity and identification with limited data. A two-compartment insulin kinetics model and associated insulin-glucose pharmacodynamics are presented. Similarities with C-peptide kinetics are used to simplify parameter identification. Critical patient specific parameters are identified using a novel convex, integral-based method. The model and methods are validated within physiological ranges using euglycaemic clamp (N=146) and IVGTT data. The mean absolute errors in the resulting glucose and insulin profiles are e G = 5.9% ± 6.6% SD and e I = 6.2% ± 6.4% SD for the clamps and area under glucose and insulin profiles deviated and during IVGTT.

[1]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[2]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[3]  K. Tranberg,et al.  Modeling of plasma disappearance of unlabeled insulin in man. , 1978, The American journal of physiology.

[4]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[5]  L. Strindberg,et al.  Delayed transcapillary delivery of insulin to muscle interstitial fluid after oral glucose load in obese subjects. , 2005, Diabetes.

[6]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[7]  C Cobelli,et al.  The kinetics of insulin in man. II. Role of the liver. , 1987, Diabetes/metabolism reviews.

[8]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[9]  R. Eaton,et al.  Insulin removal in man: in vivo evidence for a receptor-mediated process. , 1984, The Journal of clinical endocrinology and metabolism.

[10]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[11]  E. Bonora,et al.  Renal metabolism of C-peptide in man. , 1987, The Journal of clinical endocrinology and metabolism.

[12]  C. Doran,et al.  Modelling and control of hyperglycemia in critical care patients , 2004 .

[13]  Christopher E. Hann,et al.  Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia , 2005, Int. J. Intell. Syst. Technol. Appl..

[14]  A. Mari,et al.  Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis , 1998, Diabetologia.

[15]  J Keilson,et al.  Transfer times across the human body. , 1972, The Bulletin of mathematical biophysics.

[16]  Christopher E. Hann,et al.  Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model , 2005, Comput. Methods Programs Biomed..

[17]  J. Mann,et al.  Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. , 2002, Diabetes care.

[18]  K. Polonsky,et al.  Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  K. M. Erickson,et al.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. , 1980, The Journal of clinical endocrinology and metabolism.

[20]  A Mari,et al.  Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. , 2000, American journal of physiology. Endocrinology and metabolism.

[21]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[22]  R. Hovorka,et al.  Measuring prehepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule , 1998, Diabetologia.

[23]  Geltrude Mingrone,et al.  Insulin Clearance in Obesity , 2003, Journal of the American College of Nutrition.

[24]  J Geoffrey Chase,et al.  Targeted glycemic reduction in critical care using closed-loop control. , 2005, Diabetes technology & therapeutics.

[25]  C Cobelli,et al.  Estimation of β-Cell Sensitivity From Intravenous Glucose Tolerance Test C-Peptide Data: Knowledge of the Kinetics Avoids Errors in Modeling the Secretion , 1995, Diabetes.